Directory
>
Daniel Afar
Daniel Afar
Vice President, Project Leadership, Oncology Early Development | AbbVie
Redwood City, California, United States
Daniel Afar
Summary
Daniel Afar is a seasoned executive in the biopharmaceutical industry, currently serving as the Vice President of Project Leadership in Oncology Early Development at AbbVie. With a robust academic background including a PhD in Biochemistry and a Post-Doctoral fellowship in Molecular Biology, Daniel has a wealth of experience in drug development and clinical research. He has led numerous successful therapeutic antibody programs and has a proven track record in oncology and immuno-oncology. His leadership style emphasizes cross-functional collaboration and agility, enabling rapid decision-making in complex projects. Daniel's career spans over two decades, with significant roles at leading pharmaceutical companies including Merck and Facet Biotech. He is passionate about advancing cancer therapies and is known for his strategic vision in early development programs. Outside of work, Daniel is likely to engage in scientific discussions and contribute to the broader life sciences community.
Daniel Afar
Work Experience
Vice President, Project Leadership, Oncology Early Development at
AbbVie
September 2019 - Present
Group Project Leader, Oncology Early Development at
AbbVie
January 2017 - September 2019
Head of Development, AbbVie Biotherapeutics at
AbbVie
August 2013 - January 2017
Executive Director, Clinical Research at
Merck
September 2010 - August 2013
Senior Director, Program Leader, Oncology Programs at
Facet Biotech
November 2007 - September 2010
Director, Oncology Research at
PDL BioPharma
October 2004 - November 2007
Associate Director, Research at
PDL BioPharma
April 2003 - October 2004
Senior Scientist at
Eos Biotechnology
September 2000 - April 2003
Research Scientist at
Agensys
May 1997 - August 2000
Daniel Afar
Education
Frequently Asked Questions about Daniel Afar
What is Daniel Afar email address?
Daniel Afar's primary email address is ***********@abbvie.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Daniel Afar work for?
Daniel Afar is a Vice President, Project Leadership, Oncology Early Development at AbbVie, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Daniel Afar graduated from?
Daniel Afar holds a degree in Biology, Pharmacology from McGill University.
How can I directly contact Daniel Afar?
To contact Daniel Afar directly, you can use the email address ***********@abbvie.com. Complete contact information is available upon registration with Muraena.
Who is Daniel Afar?
Daniel Afar is a seasoned executive in the biopharmaceutical industry, currently serving as the Vice President of Project Leadership in Oncology Early Development at AbbVie. With a robust academic background including a PhD in Biochemistry and a Post-Doctoral fellowship in Molecular Biology, Daniel has a wealth of experience in drug development and clinical research. He has led numerous successful therapeutic antibody programs and has a proven track record in oncology and immuno-oncology. His leadership style emphasizes cross-functional collaboration and agility, enabling rapid decision-making in complex projects. Daniel's career spans over two decades, with significant roles at leading pharmaceutical companies including Merck and Facet Biotech. He is passionate about advancing cancer therapies and is known for his strategic vision in early development programs. Outside of work, Daniel is likely to engage in scientific discussions and contribute to the broader life sciences community.
Daniel`s contact details
***********@abbvie.com
Colleagues
Vice President, Search and Evaluation & Global Alliances
Founder
Senior Vice President, Chief Ethics and Compliance Officer and Allergan Aesthetics Legal
Vice President, International Marketing and Commercial Operations
Vice President, Regulatory Affairs (Regulatory Intercontinental, Regulatory Policy & Intelligence)
Vice President Europe Region North
VP and Head, US Commercial BTS, Patient Services, Market Access and Commercial Data Mgmt.
GMA Chief of Staff, Director of Global Initiatives & Communication
Vice President, Health Economics and Outcomes Research (Immunology, Oncology & Neuroscience)
Vice President WesternEurope & Canada